Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Mersana Therapeutics
Scientific Title
A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b